Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Women tend to be diagnosed with heart failure five years older than men, but have a better prognosis, finds research published in the European Journal of Heart Failure.

Aim: To understand gender differences in the prognosis of women and men with heart failure, we compared mortality, cause of death and survival trends over time. Patient characteristics: Aged >45. New diagnosis of heart failure. Diagnosed between 1 January 2000 and 31 December 2017. Number included 29234 men and 26725 women who were diagnosed with heart failure, including 15,084 men who died and 15822 women, within the study period of 17 years. The median age of diagnosis was 74.8 for men, 79.6 for women. The median survival following diagnosis was 4.47 years for men and 3.99 years for women. Cause of death in men: CVD (56.1%), primary heart failure (6.1%), heart failure any (41.8%) and non-CVD (43.9%). Cause of death in women: CVD (55.2%), primary heart failure (8.4%), heart failure any (42.9%) and non-CVD (44.8%). Women had a 14% lower age-adjusted risk of all-cause mortality compared to men. Logos - Oxford University NDPCHS, Wellcome, Funded by NIHR.

The researchers, from Oxford University’s Nuffield Department of Primary Care Health Sciences, analysed routinely collected health records from 26,725 women and 29,234 men aged over 45 years with a new diagnosis of heart failure between 2000 and 2017.

Commenting on the analysis, lead author Dr Clare Taylor, NIHR Academic Clinical Lecturer and GP, said: "It’s important to look at the differences in men and women with heart failure. We already know that women are less likely to be investigated in accordance with guidelines and to receive evidence-based therapies. For the first time, we explored the long term survival of women using a large primary care dataset including over 25,000 women with heart failure". 

"We found women are five years older when they are diagnosed and while their survival compared to men is better, the improvements in survival seen in men over the last 20 years haven’t been seen for women. The women that have the best survival are those diagnosed in the community, rather than in hospital".

“Our research highlights the need to address gender differences in diagnosis and treatment to improve survival for both men and women”. 

Co-author, Dr Nicholas Jones, Wellcome Trust Doctoral Research Fellow and GP, added: “More research is needed to understand the extent to which these results may reflect differences in categories of heart failure. Women are more likely to develop heart failure with preserved ejection fraction, for which there remains limited treatment. In contrast, we know the therapies to treat heart failure with reduced ejection fraction, more common in men, can significantly improve outlook.

The study used data from the Clinical Practice Research Data Link, inpatient Hospital Episode Statistics and the Office for National Statistics death registry. It was funded by the National Institute for Health Research CLAHRC Oxford and the Wellcome Trust.

READ MORE:

National trends in heart failure mortality in men and women, United Kingdom, 2007-2017
Taylor CJ, Ordóñez‐Mena  JM, Jones NR, Roalf AK, Lay-Flurrie S, Marshall T, Hobbs RFD
European Journal of Heart Failure https://doi.org/10.1002/ejhf.1996

Latest news

Professor Mina Fazel appointed Chair of Child and Adolescent Psychiatry

NIHR ARC OxTV researcher Professor Mina Fazel appointed as new Chair of Child and Adolescent Psychiatry at Oxford, focusing on improving access to mental health interventions for youth.

Ray Fitzpatrick FMedSci, 1950-2024

NIHR ARC OxTV saddened by the loss of Ray Fitzpatrick, a visionary researcher who led the 'Improving Health and Social Care' theme and made significant contributions to the field of health research.

Unique research collaboration highlights innovative approaches for post-pandemic healthcare

Exploring groundbreaking NHS projects that enhance post-pandemic healthcare through innovative approaches and collaborative research, focusing on remote healthcare, service delivery improvements, and workforce innovation.

New online tool that empowers parents to treat child anxiety could expand access to child mental health services

New ARC OxTV supported research shows an online program empowering parents to use cognitive behavioral therapy to treat child anxiety is as effective as in-person therapy but more accessible and scalable.

NIHR ARC OxTV Secures 18-Month Extension to Enhance Health and Care Research in Thames Valley

The NIHR Applied Research Collaboration (ARC) Oxford and Thames Valley is thrilled to announce it has received an 18-month extension to its research programme, thanks to additional funding from the Department of Health and Social Care (DHSC). This extension, which runs until March 2026, provides the ARC with £2.7 million to continue its vital work in the region.

Number of non-COVID-19 deaths among people with diabetes soared during pandemic: ARC EM and OxTV supported study

New research reveals concerning pandemic-related increases in non-COVID deaths and diabetes complications, disproportionately impacting women, youth and minorities.